Viewing Study NCT06915766

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 4:05 PM
Ignite Modification Date: 2026-01-28 @ 1:17 PM
Study NCT ID: NCT06915766
Status: AVAILABLE
Last Update Posted: 2025-11-05
First Post: 2025-03-31
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Expanded Access to Bezuclastinib for Patients With NonAdvanced Systemic Mastocytosis or Advanced Systemic Mastocytosis
Sponsor: Cogent Biosciences, Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Systemic Mastocytoses, Indolent View
None Systemic Mastocytoses, Aggressive View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Systemic Mastocytosis View
None NonAdvanced Systemic Mastocytosis View
None Advanced Systemic Mastocytosis View
None Systemic Mastocytosis with an associated hematologic neoplasm (SM-AHN) View
None Aggressive Systemic Mastocytosis (ASM) View
None Mast Cell Leukemia (MCL) View
None Bone Marrow Mastocytosis (BMM) View